跳至主要内容
临床试验/NCT00985010
NCT00985010终止不适用

Manganese, Possible Factor of Higher Mortality in Women With Encephalopathy

Materno-Perinatal Hospital of the State of Mexico1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2003年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
9
试验地点
1
主要终点
Clinical Evolution

研究概览

简要总结

Objective:

Report manganese serum levels and mortality in encephalopathic patients.

Patients and participants:

Consecutive patients aged > 18 years, with hepatic encephalopathy and informed consent signed by their families.

Interventions:

Patients' clinical characteristics as well as biochemical tests of renal function, hemoglobin, glucose and albumin levels were obtained as well as a blood sample to analyze manganese levels with a graphite furnace atomic absorption spectrometer.

Hypothesis:

There is a difference in the manganese levels between male and female patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive patients aged > 18 years
  • With hepatic encephalopathy
  • Informed consent signed by their families

排除标准

  • Portal bypass surgery
  • Cancer of any localization
  • Known malignancy and other severe diseases which shorten life expectancy < 6 months
  • Psychiatric illness

结局指标

主要结局

Clinical Evolution

时间窗: six months

Number of participants who died versus those who remained alive after 6 months of follow up since the first entrance at the Emergency Room

次要结局

  • Manganese Levels(Up to six months we followed the recruited patients to determine who were still alive)

研究者

发起方
Materno-Perinatal Hospital of the State of Mexico
申办方类型
Other

研究点 (1)

Loading locations...

相似试验